Graham Capital Management, L.P. Gossamer Bio, Inc. Transaction History

Graham Capital Management, L.P.

  • $4.42 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.51 - $1.27 $4,405 - $10,970
-8,638 Reduced 45.17%
10,484 $9,000
Q1 2024

May 15, 2024
BUY
$0.8 - $1.51 $15,297 - $28,874
19,122 New
19,122 $22,000
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $1.09 Million - $2.24 Million
150,656 New
150,656 $1.8 Million

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $78.9M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email